ACS Clinical Research Program rss

ACS CRP

Atezolizumab in the adjuvant treatment of stage III colon cancer: Can PD-L1 inhibition improve survival?(0)

March 1, 2019

The study design for the ATOMIC trial (Alliance A021502), a randomized phase III study examining atezolizumab treatment of stage III colon cancer, is described.

Figure 1. PRODIGE 7 trial design

Cytoreduction with or without HIPEC: Where do we go from here?

Summarizes the results of the PRODIGE 7 trial, which compared the addition of hyperthermic intraperitoneal chemotherapy with contemporary perioperative systemic chemotherapy and cytoreduction.

ACS CRP

Robotic surgery for hepatic neoplasms: Where does it fit in the minimally invasive surgery landscape?

This month’s column identifies prospective clinical trials aimed at clarifying the role of laparoscopic and robotic surgery for hepatic neoplasms.

ACS CRP

Surveillance testing for colorectal cancer: New evidence supports a change in guidelines

New studies are identified suggesting that more frequent or intensive surveillance testing may not result in earlier detection of cancer recurrence.

Figure 1. Trends in colorectal cancer incidence rates by age and year of birth, and by age and year of diagnosis, U.S., 1975 to 2014

Colorectal cancer in adults younger than 50 years old

Colorectal screening options for patients younger than 50 years of age and trends in colorectal cancer rates for this age group are summarized.


More in this category

« Older Posts   

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611

Archives

Download the Bulletin App

Apple Store
Get it on Google Play
Amazon store